InvestorsHub Logo

grobtekrebssvindl

04/27/15 10:31 AM

#5496 RE: WeeZuhl #5494

"HER2-Specific."That is 6 years old news,shorts,AMBS

"'WeeZuhl'
"HER2-Specific Vaccines for HER2-Positive Breast Cancer Immunotherapy

World Journal of Vaccines, 2015, 5, 106-128
Received 19 March 2015; accepted 18 April 2015; published 24 April 2015 "


That is 6 years old news ( similar news,nothing since)..even the fraud Generex could not post this first time right,people on yahoo corrected it,so Generex posted SECOND time..shows how amateur Generex is,the management reads posts and even posts!

VS

December 15, 2009
Generex Clarifies Previous Announcement of Breast Cancer Study Interim Results

http://investor.generex.com/releasedetail.cfm?ReleaseID=430265

Shorts went up from 32,900 to 144,000,basically zero,irrelevant

Since AMBS was topic on yahoo:they had the lie on May 31, 2011

"Generex will make a three-year $5 million commitment to that collaboration.. Amarantus will pay a license fee of $10 Million to Generex"..

Generex never had 5 millions,they knew they never will have!

http://investor.generex.com/releasedetail.cfm?ReleaseID=581883


AMBS TERMINATED!! the contract 26th day of March 2013,what the fraud liar Generex NEVER made public ( securities fraud,by law,25 years jail,that is fact),I!! posted on Yahoo board,only!

http://www.getfilings.com/sec-filings/130401/AMARANTUS-BIOSCIENCE-INC_8-K/v339996_ex10-1.htm

""There are three kinds of lies: lies, damned lies, and statistics." Exatly! :o)